Nanoparticles for the potential treatment of osteoporosis

Written by Daniel Lozano, María Vallet-Regí, Miguel Manzano, Patricia Mora-Raimundo

In this original editorial piece, María Vallet-Regí, Patricia Mora-Raimundo, Daniel Lozano and Miguel Manzano (all at the Universidad Complutense de Madrid, Spain) discuss the use of nanoparticles for the potential treatment of osteoporosis, in light of some of their recently published work in the field. In the last few decades, the global life expectancy has risen considerably, which has consequently increased the impact of skeletal diseases, such as osteoporosis. In this sense, osteoporosis is defined by the WHO as a ‘progressive systemic skeletal disease characterized by low bone mass and microarchitectural deterioration of bone tissue, with a consequent increase in bone...

To view this content, please register now for access

It's completely free